Coronavirus Vaccine Developers Jump As Rival AstraZeneca Pauses TrialsInvestors Business Daily • 09/09/20
Factbox: Scientists, drugmakers and traders react to AstraZeneca's COVID-19 vaccine trial pauseReuters • 09/09/20
AstraZeneca shares drop 6% after company announces 'routine' safety pause in vaccine trialCNBC • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20